Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q3 2017 · 10-Q
Revenue$319.02K$319.02K+35.1% vs Q3 2016 Net Income$35.41K$35.41KN/M vs Q3 2016 EPS Diluted$0.00$0.00— vs Q3 2016 Gross Profit$170,351+39.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$38,160+138.8% Free Cash Flowderived$28,027+10,934.3% Margins · derivedGross margin53.4%+1.5 pt vs Q3 2016
Operating margin10.4%+15.5 pt vs Q3 2016
Net margin11.1%+16.1 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 13, 2017 · 44 d after period end